The Journal of
Clinical Psychiatry

Insights Emerging Approaches in Schizophrenia October 31, 2024

Prevalence and Determinants of Everyday Disability in Schizophrenia

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

About the Authors

Philip D. Harvey, PhD

View full profile

Save

Cite

Read the Current Issue

Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Original Research

Valbenazine in Elderly Adults With Tardive Dyskinesia

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Original Research

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Brief Report

Psychosocial Correlates of Optimism among US Military Veterans

View current Issue

Insights

What Is the Role of the Muscarinic Receptor System in Schizophrenia?

November 19, 2024

In this video, Dr. Correll discusses the role of the muscarinic receptor system in schizophrenia, exploring its impact on cognitive and functional outcomes. He examines the potential for targeting...

Christoph U. Correll

Insights

What are the Efficacy and Safety of Muscarinic Receptor Modulators in Patients With Schizophrenia?

November 19, 2024

In this video, Dr. Correll examines the therapeutic potential of the muscarinic receptor system in schizophrenia treatment. He discusses how targeting muscarinic receptors may address cognitive and functional impairments,...

Christoph U. Correll

Insights

What is the Place of Muscarinic Receptor Modulators in the Clinical Care of Patients With Schizophrenia?

November 19, 2024

This video features Dr. Christoph Correll discussing the clinical application of muscarinic receptor modulators in schizophrenia treatment. He explores their unique mechanism of action, compares them to traditional antipsychotics,...

Christoph U. Correll

Prevalence and Determinants of Everyday Disability in Schizophrenia

About the Authors

Read the Current Issue

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Valbenazine in Elderly Adults With Tardive Dyskinesia

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Psychosocial Correlates of Optimism among US Military Veterans

ELSEWHERE:

FOLLOW US:

Prevalence and Determinants of Everyday Disability in Schizophrenia

Free Access: Please Log In

About the Authors

Read the Current Issue

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Valbenazine in Elderly Adults With Tardive Dyskinesia

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Psychosocial Correlates of Optimism among US Military Veterans

Related Articles

What Is the Role of the Muscarinic Receptor System in Schizophrenia?

What are the Efficacy and Safety of Muscarinic Receptor Modulators in Patients With Schizophrenia?

What is the Place of Muscarinic Receptor Modulators in the Clinical Care of Patients With Schizophrenia?

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles